The California State Board of Pharmacy (BOP) is delaying its final vote on new compounding drug regulations after being ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.

A new book offers feedback from experts on the state of schizophrenia treatment and research, with new perspectives and ...

The California State Board of Pharmacy (BOP) hopes a key vote on January 8th will go largely unnoticed, even though it will ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other ...

A research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other neurodegenerative disorders such as ...

If you or a loved one is showing potential signs of age-related cognitive decline or dementia, you may want to seek help but not know the right type of health care provider to choose. That' ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington’s disease and link HD with other ...

In neuroscientific research, gaining a deep understanding of the human nervous system's structure and dynamics is pivotal. Despite remarkable advancements ...

The U.S. isn't fully capturing spread in pets like cats, compared to surveillance for livestock and people, said the study’s senior author, Suresh Kuchipudi, a professor and chair of infectious ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...